Alector (ALEC) Other Non-Current Assets (2018 - 2026)
Alector's (ALEC) quarterly Other Non-Current Assets came in at $1.8 million in Q2 2026, little changed year-over-year from $1.8 million in Q2 2025, and little changed quarter-over-quarter from $1.8 million in Q1 2026.
Analysis
Alector (ALEC) Other Non-Current Assets (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Other Non-Current Assets for 9 consecutive years, with $1.8 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $1.8 million in Q2 2026; TTM through Jun 2026 was $1.8 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $1.8 million, down 59.38% from the prior year.
- Other Non-Current Assets was $1.8 million for Q2 2026 at Alector, roughly flat from $1.8 million in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $7.4 million in Q4 2023 and troughed at $1.5 million in Q1 2022.
- A 5-year average of $2.5 million and a median of $1.7 million in 2023 frame the typical range for Other Non-Current Assets.
- The widest YoY moves for Other Non-Current Assets: up 189.2% in 2025, down 59.38% in 2025.
- Over 5 years, Other Non-Current Assets stood at $6.4 million in 2022, then increased by 15.74% to $7.4 million in 2023, then plunged by 38.74% to $4.5 million in 2024, then plunged by 59.38% to $1.8 million in 2025, then changed by 0.0% to $1.8 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.8 million (Q2 2026), $1.8 million (Q1 2026), and $1.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 12.98 Bn |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 4.75 Bn |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 1.25 Bn |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 2.31 Bn |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 124.00 Mn |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | 618.00 Mn |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 831.80 Mn |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | 1.85 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.85 Mn |
| Mar 31, 2026 | 1.85 Mn |
| Dec 31, 2025 | 1.85 Mn |
| Sep 30, 2025 | 4.47 Mn |
| Jun 30, 2025 | 1.85 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 4.54 Mn |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.55 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 7.42 Mn |
| Sep 30, 2023 | 1.55 Mn |
| Jun 30, 2023 | 1.55 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 6.41 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.47 Mn |
| Mar 31, 2022 | 1.47 Mn |
| Dec 31, 2021 | 5.57 Mn |
| Sep 30, 2021 | 1.47 Mn |